RESEARCH, TRADITIONS AND SAFETY

Skin cancer

Skin cancer has different types. A supplement result for basal- or squamous-cell cancer does not establish a benefit for melanoma. None of these materials treats a suspicious spot.

Nonmelanoma prevention, melanoma boundaries and dangerous topical products. Relevant to all adults.

A linen sun hat beside a notebook with a sun-and-shield motif
Decorative topic illustration.

Care basics come first

How we chose these entries

A curated set of useful materials and cautionary examples, not a worldwide ranking. Negative and safety entries are not benefit recommendations.

Five high-value entries were retained: a limited prevention finding, two negative supplement examples, one urgent safety reference and one reported tradition. There is no defensible 20-item list of skin-cancer remedies. Historical labels are not retrospectively assigned to melanoma or squamous-cell cancer.

Prevention and treatment are different roles

Prevention belongs here alongside treatment research, with the role and evidence stated separately. Lower sunburn or laboratory UV damage does not by itself demonstrate fewer skin cancers. None of the oils, foods or supplements below treats an existing skin cancer. Changing, bleeding or nonhealing spots need medical assessment.

UV protection comes first

  • Seek shade and wear covering clothing, a wide-brimmed hat and UV-protective sunglasses; UPF-labelled clothing adds a tested protection measure.
  • On uncovered skin, use a broad-spectrum, water-resistant sunscreen with SPF 30 or higher. Reapply every two hours outdoors and after swimming or sweating, following the label.
  • Zinc oxide and titanium dioxide are sunscreen active ingredients, but protection belongs to the tested finished product. An ointment, loose powder or homemade oil mixture is not automatically a sunscreen.

Carrot seed oil: used in sun-care claims, not a reliable sunscreen

Carrot seed essential oil, fixed seed oil and carrot-root/carotene preparations are different materials; evidence cannot be transferred between them. A 2021 study testing vegetable oils by an ISO human SPF method found only low UVB protection for its carrot-seed oil sample. A 2026 laboratory study also found negligible protection from the tested carrot-seed oil. Neither supports a broad-spectrum sunscreen claim, cancer-prevention claim or DIY SPF recipe. A finished sunscreen can contain carrot ingredients while obtaining protection from its actual UV filters.

Promising adjuncts are not cancer treatment

Small studies of a specific oral Polypodium extract and tomato paste measured sunburn responses or photodamage markers. These are adjunct research leads, not established skin-cancer prevention or permission to stay in the sun longer. Nicotinamide has a separate, limited prevention result in selected high-risk adults; it is not sunscreen.

Nicotinamide: selected prevention research

  • ONTRAC randomized 386 adults with at least two prior nonmelanoma skin cancers in five years: 500 mg nicotinamide twice daily for 12 months reduced new keratinocyte cancers by 23% versus placebo during treatment, without sustained benefit after stopping. This is a study regimen, not personal dosing advice. A separate 158-participant transplant trial found no benefit and stopped early for poor recruitment.
  • No demonstrated treatment of existing lesions or melanoma benefit. NCI regards overall preventive evidence as inadequate.

Beta-carotene pills: no established skin-cancer prevention

  • Randomized trials have not established nonmelanoma skin-cancer prevention from beta-carotene pills. High-dose beta-carotene increased lung-cancer risk in smokers in major prevention trials. This is not a warning against ordinary vegetables.

8 reviewed records

UV-protection research

Changes in redness or laboratory UV markers do not establish skin-cancer prevention or treatment.

UV-protection research

Tomato paste: dietary photoprotection research

Tomato paste in a plain dish, with tomato and separate olive-oil cruet.
Decorative illustration; not an identification reference. Generic format context; actual studied or finished product not shown.

Edible ripe tomato fruit

Form
Tomato paste consumed with olive oil in the trial
How it is used
oral food
Evidence
Small randomized human trial; surrogate outcomes

A small trial found changes in UV-related redness and photodamage markers after tomato paste.

Cancer type and setting

Skin-cancer prevention context; no existing-cancer treatment claim

Cautions

  • Food is an adjunct to normal sun protection, not a substitute. Do not apply tomato paste to a suspicious lesion.

Read full ingredient card: Tomato

Evidence, limits and sources for Tomato paste: dietary photoprotection research

What was found

Twenty healthy women consumed tomato paste with olive oil or olive oil alone for 12 weeks. Some instrument-measured redness and skin-damage markers improved; the visually assessed minimal erythema dose was not significantly different.

What this does not show

This did not test skin-cancer incidence. Findings do not establish a sunscreen effect or benefits from every tomato food or isolated lycopene supplement.

Exact ingredient

Exact match to card 411 edible tomato fruit/paste; not isolated lycopene or topical plant extracts.

Why we included it

Adds a distinct prevention or photoprotection evidence role without implying treatment.

Sources

UV-protection research

Polypodium leucotomos: early photoprotection research

Closed unlabelled amber research-extract container.
Decorative illustration; not an identification reference. Generic format context; actual studied or finished product not shown.

Studied fern extract; botanical part not specified in the inspected abstract

Form
Specific oral extract used in a placebo-controlled trial
How it is used
oral
Evidence
Small randomized placebo-controlled human trial; surrogate outcomes

A small short-term trial found reduced UV-related redness and sunburn measures.

Cancer type and setting

Skin-cancer prevention context; no existing-cancer treatment claim

Cautions

  • Discuss supplement use with a clinician, especially during cancer treatment. Continue sunscreen, clothing and shade.

Why no exact ingredient link?

No exact existing card found. Keep as a topic-only research reference until exact botanical part and product specification are fully documented.

Evidence, limits and sources for Polypodium leucotomos: early photoprotection research

What was found

A 60-day trial of oral extract reported better sunburn and UV-redness measures and no changes in its safety assessments.

What this does not show

No skin-cancer prevention or treatment outcome was established. Short-term safety findings do not establish long-term safety, use in pregnancy or suitability for every patient. Generic fern teas and other extracts are not interchangeable.

Exact ingredient

No exact existing card found. Keep as a topic-only research reference until exact botanical part and product specification are fully documented.

Why we included it

Adds a distinct prevention or photoprotection evidence role without implying treatment.

Sources

Care and risk-reduction research

Read the outcome, preparation and limits. A studied benefit does not make every product effective.

Risk reduction

Nicotinamide (niacinamide)

Engraved study of Beans (fava / broad beans). Source-plant study: Beans (fava / broad beans)
Ingredient reference illustration: Vitamin B3 Niacin. Studied form: Oral nicotinamide tablets. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Isolated vitamin B3 form

Form
Oral nicotinamide tablets
How it is used
oral
Evidence
One positive randomized trial; limited generalizability

May lower new nonmelanoma skin cancers in selected high-risk adults while taken.

Cancer type and setting

Basal-cell and cutaneous squamous-cell carcinomas; high-risk prevention

Cautions

  • Discuss with a dermatologist. Nicotinic acid and skin creams are not interchangeable with these tablets.

Read full ingredient card: Vitamin B3 Niacin

Evidence, limits and sources for Nicotinamide (niacinamide)

What was found

ONTRAC enrolled 386 adults with at least two prior nonmelanoma skin cancers. New cancers fell 23% during one year; benefit did not persist after stopping.

What this does not show

Not proof for melanoma, everyone, or treatment of an existing lesion. NCI describes overall evidence as inadequate; a separate transplant trial found no benefit.

Exact ingredient

Card 43 explicitly distinguishes nicotinamide from nicotinic acid and topical forms; attach only this oral-form association.

Why we included it

Separates a real prevention finding from broad B3 claims.

Sources

Risk reduction

Zinc oxide: finished sunscreen

Unlabelled sunscreen tube beside a curl of finished cream.
Decorative illustration; not an identification reference. Generic format context; actual studied or finished product not shown.

Zinc oxide active ingredient

Form
Tested finished broad-spectrum sunscreen, not a generic zinc ointment
How it is used
topical
Evidence
FDA/AAD guidance; finished-sunscreen clinical evidence

A tested broad-spectrum sunscreen is part of recommended UV-risk reduction.

Cancer type and setting

Skin-cancer prevention context; no existing-cancer treatment claim

Cautions

  • Follow the finished product label. Do not make sunscreen by mixing powder into oil or lotion.

Why no exact ingredient link?

Related zinc-oxide ingredient profile; not a match to a particular tested finished sunscreen.

Evidence, limits and sources for Zinc oxide: finished sunscreen

What was found

FDA lists zinc oxide as a sunscreen active. AAD recommends broad-spectrum, water-resistant SPF 30 or higher sunscreen with shade and clothing.

What this does not show

Do not assign an SPF from zinc concentration or from the ingredient alone. Cancer-trial results for sunscreen do not establish zinc oxide as cancer treatment.

Exact ingredient

Related zinc-oxide ingredient profile; not a match to a particular tested finished sunscreen.

Why we included it

Adds a distinct prevention or photoprotection evidence role without implying treatment.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources

Tradition and early research

These historical reports or laboratory findings do not establish a clinical benefit.

Traditional reports

Pistacia palaestina: reported skin use

Pistacia palaestina leaf reference
Ingredient reference illustration: Pistacia palaestina leaf reference. Studied form: Reported traditional paste; not a clinical product. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Pistacia palaestina · Leaves

Form
Reported traditional paste; not a clinical product
How it is used
topical; historical record only
Evidence
Ethnobotanical survey only

A West Bank survey recorded leaf-paste use for skin cancer.

Cancer type and setting

Skin cancer; subtype unspecified in the report

Cautions

  • Do not put homemade preparations on a suspicious lesion or postpone examination.

Read full ingredient card: Pistacia palaestina leaf reference

Evidence, limits and sources for Pistacia palaestina: reported skin use

What was found

This was an interview record, not a treatment trial.

What this does not show

No skin-cancer subtype or successful outcome was verified. The leaf is not mastic resin.

Exact ingredient

No exact existing material match found in the 570-card inventory.

Why we included it

Preserves a consistent skin-specific historical record.

Sources

Safety and no-benefit findings

These records explain what to avoid or why a proposed benefit is not established.

No benefit or possible harm

Selenium-enriched yeast

Engraved source or material study: three Brazil nuts with one opened shell.
Ingredient reference illustration: Selenium. Studied form: Oral selenium-enriched yeast tablets. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Selenium in yeast

Form
Oral selenium-enriched yeast tablets
How it is used
oral
Evidence
Randomized trial evidence of no benefit and harm

Selenium is not a skin-cancer prevention supplement.

Cancer type and setting

Cutaneous squamous-cell carcinoma and basal-cell carcinoma

Cautions

  • Do not take selenium to prevent skin cancer.

Read full ingredient card: Selenium

Evidence, limits and sources for Selenium-enriched yeast

What was found

In people with prior basal- or squamous-cell cancers, a trial found no clear basal-cell benefit and increased squamous-cell and total keratinocyte cancers.

What this does not show

Does not show ordinary selenium-containing foods are harmful.

Exact ingredient

Existing card explicitly covers this part and form; keep the claim limited to this preparation.

Why we included it

Clarifies a commonly confused claim.

Sources

No benefit or possible harm

Beta-carotene supplements

Engraved carrot root with a leafy top; a food source of provitamin A carotenoids.
Ingredient reference illustration: Vitamin A. Studied form: Oral supplement. This does not verify the trial product or formulation, or show that it works. Decorative illustration; not an identification reference.

Isolated provitamin A carotenoid

Form
Oral supplement
How it is used
oral
Evidence
Randomized prevention trials

Beta-carotene pills have not prevented nonmelanoma skin cancer.

Cancer type and setting

Basal-cell and cutaneous squamous-cell carcinomas

Cautions

  • High-dose beta-carotene also raises lung-cancer risk in smokers.

Read full ingredient card: Vitamin A

Evidence, limits and sources for Beta-carotene supplements

What was found

NCI summarizes randomized trials without a prevention benefit.

What this does not show

This result concerns supplements, not vegetables.

Exact ingredient

Card 40 explicitly includes beta-carotene supplement forms; the association must not imply all vitamin A forms are identical.

Why we included it

Clarifies a commonly confused claim.

Sources

Safety reference

Black salve: avoid

Safety reference symbol; no product shown
Safety reference. The specific research preparation or product is not pictured. This symbol marks an evidence or safety record, not a recommended remedy.

Variable mixture; may contain bloodroot and zinc chloride

Form
Corrosive topical salve
How it is used
topical; unsafe use reference only
Evidence
Regulator safety warning

Do not use black salve on a suspected skin cancer.

Cancer type and setting

Suspected skin cancers, including lesions without a confirmed subtype

Cautions

  • Seek medical help for a nonhealing or changing lesion; do not repeat the application.
Evidence, limits and sources for Black salve: avoid

What was found

FDA warns that corrosive salves can injure tissue and delay diagnosis, allowing cancer to progress.

What this does not show

A wound or scab after use does not prove a cancer was removed.

Exact ingredient

A variable salve is not a zinc nutrient supplement or an exact match to card 58. Keep as a warning-only topic reference.

Why we included it

Clarifies a commonly confused claim.

Related material only

These are different ingredients or forms. Do not assume the same findings apply to them.

Sources